(S) -Lomedeucitinib
(S) -Lomedeucitinib ((S) -BMS-986322) is a S-enantiomer of Lomedeucitinib (HY-160144S) . Lomedeucitinib is a tyrosine protein kinase (TYK2) inhibitor[1].
Product Specifications
CAS Number
[2328068-38-6]
Product Name Alternative
(S) -BMS-986322
UNSPSC
12352005
Target
JAK
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Inflammation/Immunology
Purity
99.09
Smiles
O=C(C1=NN=C(NC([C@H]2CC23CC3)=O)C=C1NC4=NC=CC=C4S(=O)(C)=O)NC([2H])([2H])[2H]
Molecular Formula
C18H17D3N6O4S
Molecular Weight
419.47
References & Citations
[1]Drakos A, et al. Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents[J]. Pharmaceutics, 2024, 16 (1) : 111.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC200355L3V 200 µL
PAFAH2 (NM_000437) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 